4492 — Genetec Income Statement
0.000.00%
Last trade - 00:00
- ¥11bn
- ¥10bn
- ¥6bn
- 87
- 24
- 88
- 79
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,483 | 4,720 | 4,079 | 4,683 | 5,864 |
Cost of Revenue | |||||
Gross Profit | 1,510 | 1,609 | 1,562 | 1,962 | 2,318 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,227 | 4,385 | 3,825 | 4,631 | 5,782 |
Operating Profit | 256 | 336 | 254 | 52.6 | 82.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 277 | 327 | 276 | 117 | 87.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 180 | 213 | 173 | 56.6 | 23.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 180 | 213 | 173 | 56.6 | 23.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 180 | 213 | 173 | 56.6 | 23.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 20.3 | 22.5 | 15.3 | 10.8 | 6.74 |
Dividends per Share | |||||
Special Dividends per Share |